<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="68685">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01737840</url>
  </required_header>
  <id_info>
    <org_study_id>160</org_study_id>
    <nct_id>NCT01737840</nct_id>
  </id_info>
  <brief_title>Comparison of Pantoprazole and Ranitidine in Dyspepsia</brief_title>
  <official_title>Intravenous Pantoprazole vs Ranitidine in Dyspepsia in Emergency Department: A Randomized Controlled Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Akdeniz University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Akdeniz University</source>
  <oversight_info>
    <authority>Turkey: Ministry of Health</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The H0 hypothesis of the study there is no difference between pantoprazole and ranitidine in
      treating patients presented with dyspepsia to the emergency deparment.

      The H1 hypothesis is there is difference between pantoprazole and ranitidine in treating
      patients presented with dyspepsia to the emergency department.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Dyspepsia is one of the common complaints in emergency department. Protone pomp inhibitors,
      H2 receptor blockers and anti-acids are common drugs for treating dyspepsia in emergency
      department. However there is no study in the emergency department comparing the
      effectiveness of these drugs. So the investigators planned this study which drug is
      effective in these patients in order to provide a cost-effective treatment in dyspeptic
      patients.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>October 2012</start_date>
  <completion_date type="Anticipated">January 2013</completion_date>
  <primary_completion_date type="Anticipated">January 2013</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Visual analogue scale score</measure>
    <time_frame>30th and 60th minutes</time_frame>
    <safety_issue>No</safety_issue>
    <description>The investigators are measuring the change of pain from the baseline to the 30th and 60th minutes by visual anologue scale.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Need for additional drug</measure>
    <time_frame>60 th minute</time_frame>
    <safety_issue>No</safety_issue>
    <description>The investigators are measuring the need for additional drug at the end of 60 minutes.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">70</enrollment>
  <condition>Dyspepsia</condition>
  <arm_group>
    <arm_group_label>pantoprazole</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Intravenous pantoprazole 40 mg flacon</description>
  </arm_group>
  <arm_group>
    <arm_group_label>ranitidine</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Intravenous ranitidine 50 mg</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Pantoprazole</intervention_name>
    <arm_group_label>pantoprazole</arm_group_label>
    <other_name>Pantpas</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ranitidine</intervention_name>
    <arm_group_label>ranitidine</arm_group_label>
    <other_name>Ulcuran</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Epigastric pain

          -  Older than 18 years old

        Exclusion Criteria:

          -  Diagnosed as cholecystitis, pancreatitis, myocardial infarction, etc.. at the end of
             the emergency deparment evaluation period.

          -  Pregnancy

          -  Patients with unstable vital signs

          -  Patients used anti-acid, H2 receptor blockers and proton pomp inhibitors in the last
             one hour.

          -  Allergy to H2 receptor blockers and proton pomp inhibitors.

          -  Patients denied to give inform consent and who are illiterate
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cenker Eken, Proffesor</last_name>
    <role>Study Director</role>
    <affiliation>Akdeniz University</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cenker Eken, Proffesor</last_name>
    <phone>00905056251217</phone>
    <email>cenkereken@akdeniz.edu.tr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Akdeniz University</name>
      <address>
        <city>Antalya</city>
        <zip>07050</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cenker Eken, Proffesor</last_name>
      <phone>00905056251217</phone>
      <email>cenkereken@akdeniz.edu.tr</email>
    </contact>
    <investigator>
      <last_name>Engin Senay, Resident</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <link>
    <url>http://www.akdeniz.edu.tr</url>
    <description>The web adress of the organization which this study is conducted.</description>
  </link>
  <reference>
    <citation>Welling LR, Watson WA. The emergency department treatment of dyspepsia with antacids and oral lidocaine. Ann Emerg Med. 1990 Jul;19(7):785-8.</citation>
    <PMID>2202240</PMID>
  </reference>
  <verification_date>November 2012</verification_date>
  <lastchanged_date>November 29, 2012</lastchanged_date>
  <firstreceived_date>November 24, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>dyspepsia</keyword>
  <keyword>pantoprazole</keyword>
  <keyword>ranitidine</keyword>
  <keyword>emergency department</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Dyspepsia</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Ranitidine</mesh_term>
    <mesh_term>Ranitidine bismuth citrate</mesh_term>
    <mesh_term>Pantoprazole</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
